Running a clinical trial for rare diseases is fundamentally different from trials in more common conditions[. Small patient populations, scarce data, and complex regulations demand greater precision and innovation. Rather than covering the basics, this article dives into advanced, practical considerations for experienced sponsors—like selecting the right countries and trial sites, and designing studies that are truly feasible and effective for rare disease populations. learn more: www.credevo.com